Figure 2
Progression-free survival for patients with stage III and IV ovarian cancer in the neoadjuvant chemotherapy and adjuvant chemotherapy groups.
Figure 2 | BMC Cancer
Progression-free survival for patients with stage III and IV ovarian cancer in the neoadjuvant chemotherapy and adjuvant chemotherapy groups.